Drug treatments for covid-19: living systematic review and network meta-analysis

…, M Azab, G Bravo, DK Chu, R Couban, E Cusano… - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

…, D Arnold, C Ávila, DK Chu, R Couban, E Cusano… - Bmj, 2021 - bmj.com
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood products
for the treatment of novel coronavirus disease 2019 (covid-19). Design Living systematic …

[HTML][HTML] Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis

D Zeraatkar, E Cusano, JPD Martínez, A Qasim… - BMJ …, 2022 - ncbi.nlm.nih.gov
… Dena Zeraatkar, corresponding author 1, 2 Ellen Cusano, 3 Juan Pablo Díaz Martínez, 4
Anila Qasim, 1 Sophia Mangala, 5 Elena Kum, 1 Jessica Julia Bartoszko, 1 Tahira Devji, 1 …

[HTML][HTML] Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis

…, R Van Alstine, G Chick, G Leung, D Mikhail, E Cusano… - Cmaj, 2022 - Can Med Assoc
Background: Randomized trial evidence suggests that some antiviral drugs are effective in
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …

Methodology and design of platform trials: a meta-epidemiological study

T Pitre, S Cheng, E Cusano, N Khan, D Mikhail… - Journal of clinical …, 2023 - Elsevier
Objectives Adaptive platforms allow for the evaluation of multiple interventions at a lower
cost and have been growing in popularity, especially during the COVID-19 pandemic. The …

[HTML][HTML] Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review

D Zeraatkar, T Pitre, G Leung, E Cusano, A Agarwal… - BMJ …, 2022 - ncbi.nlm.nih.gov
Objective To assess the trustworthiness (ie, complete and consistent reporting of key
methods and results between preprint and published trial reports) and impact (ie, effects of …

Prognostic significance of lymphovascular space invasion in the absence of lymph node metastases in early-stage endometrial cancer

E Cusano, V Myers, R Samant, T Sudai… - International Journal of …, 2018 - ijgc.bmj.com
Objective Lymphovascular space invasion (LVSI) has been defined as a significant adverse
prognostic factor in early-stage endometrial cancer, primarily because of its high association …

Identification of outcomes in clinical studies of interventions for venous thromboembolism in non‐pregnant adults: A scoping review

T Tritschler, E Cusano, N Langlois… - … of Thrombosis and …, 2022 - Wiley Online Library
Background The development of a core outcome set (COS), defined as an agreed minimum
set of outcome domains that should be measured and reported in all trials of a specific …

Value assessment of oncology drugs using a weighted criterion‐based approach

DA Ezeife, F Dionne, AF Fares, ELR Cusano… - Cancer, 2020 - Wiley Online Library
Background Globally, the rising cost of anticancer therapy has motivated efforts to quantify
the overall value of new cancer treatments. Multicriteria decision analysis offers a novel …

[HTML][HTML] Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study

OF Khan, E Cusano, S Raissouni, M Pabia, J Haeseker… - BMC cancer, 2019 - Springer
Background Cognitive impairment is commonly reported in patients receiving chemotherapy,
but the acuity of onset is not known. This study utilized the psychomotor vigilance test (PVT) …